Welcome to the 3rd World ADC Asia

3 차 Word ADC Asia 소개



3 차 Word ADC Asia 소개



The year 2024 has been considered the ‘coming of age’ era for antibody-drug conjugates, in great part due to the remarkable resurgence in drug development across the Asia-Pacific region. This part of the world is taking the ADC industry by storm with high-profile deals, multiple approvals, multiple ADCs moving into clinical trials, and novel targets being explored just to name some advancements.

Back by popular demand after a short break, the 3rd World ADC Asia is bringing together pioneers and key opinion leaders across mega-pharma and biotechnology focusing on China, Japan, Taiwan, South Korea and Singapore. They’ll be sharing their most pressing challenges, novel payloads, conjugation, and linker innovations to inform ADC development and improve targeting accuracy.

Alongside exclusive insights on the latest clinical developments taking place in the space, the many networking opportunities available will also help you build the strategic collaborations required to meet regulatory standards, understand CMC manufacturing, deal with supply chain issues, and more.

We hope you can join us at this must-attend event for the ADC Community based in the APAC region where the East will meet the West. By learning from recent innovations from the East and long-standing experts from the West, you will be able to propel your ADC development further than ever before.

2024 Expert Speakers

2024 년 전문 연사 발표

2024 专家演讲人

2024 専門家の演者

See Why Your Peers Want to Attend

동료들이 참석하고 싶어하는 이유를 확인하세요



About World ADC Series

Word ADC 시리즈 소개

关于世界 ADC 系列


The World ADC team ploughs its collective energy in to sourcing the insights you need. We investigate the most challenging problems facing the industry; source the leading experts who have game-changing solutions; and distil this into accessible formats of information exchange – for you. From globally leading conferences to webinars and industry reports, whatever the information you need, World ADC can offer you the insights you need to accelerate your ADC programs.

The value World ADC provides you is the power of insight and connections. Not artificial, and not short-lived. We nurture the right environments in which people can communicate problems and solutions; share novel data and forge networks across the industry that will make each of your endeavours more informed and more robust.

We share a common belief with the industry – that the potential of antibody drug conjugates is enormous. In the war against cancer, ADCs can be a game-changer and we know that the right insights and connections can sharpen the weapons that are in your arsenal.

Join us at the heart of the ADC community to improve your programmes and be part of the mission to develop better antibody drug conjugate drugs.

In Partnership With

파트너십 체결



Lead Partner



Event Partner